Critical Implications of IVDR for Innovation in Diagnostics: Input From the BioMed Alliance Diagnostics Task Force

Affiliations

• ¹ BioMed Alliance Task Force on In Vitro Diagnostics, Brussels, Belgium.
• ² Ad hoc Commission IVD of the Association of the Scientific Medical Societies in Germany, Berlin, Germany.
• ³ Department of Hematology, University Hospital Schleswig-Holstein, Kiel, Germany.
• ⁴ European Scientific Foundation for Laboratory Hemato Oncology, Leiden, The Netherlands.
• ⁵ European Hematology Association, The Hague, The Netherlands.
• ⁶ DG for Health and Food Safety, European Commission, Brussels, Belgium.
• ⁷ European Society of Human Genetics, Vienna, Austria.
• ⁸ University of Leuven, Belgium.
• ⁹ European Society of Cardiology, Brussels, Belgium.
• ¹⁰ Department of Immunology, Leiden University Medical Center, The Netherlands.
• ¹¹ Centro de Investigación del Cáncer-Instituto de Biología Molecular y Celular del Cáncer (CIC-IBMCC, USAL-CSIC-FICUS) and Department of Medicine, University of Salamanca, Spain.
• ¹² European Federation of Clinical Chemistry and Laboratory Medicine, Milano, Italy.
• ¹³ Department of Clinical Chemistry and Laboratory Medicine, Leiden University Medical Center, The Netherlands.
• ¹⁴ Hematology, Université Paris Cité, Assistance Publique - Hôpitaux de Paris, France.